HispanicHedge

Lipocine $LPCN 4th Submission Run-up

NASDAQ:LPCN   Lipocine Inc.
Lipocine Inc $LPCN has a PDUFA on Aug. 28 for Tlando, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men.

Lipocine Announces Derivative Suit Was Dismissed 7/31/2020
www.prnewswire.com/n...issed-301103629.html

I really like how this chart is setting up over the $1.60 level if volume continues. There is a lot of short squeeze potential in the name, and always manage your risk.

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.